View Marketing and Communications Partnership

Marketing and Communications Partnership

We are today delighted to announce the launch of a new working partnership with Vivactis – the specialist International biomedical …

Read more

View EMA Oncology Guidance

EMA Oncology Guidance

The EMA guidance is always invaluable when designing a clinical development program for products destined for the European market, and …

Read more

View Early Experiences with Scientific Advice through IRIS

Early Experiences with Scientific Advice through IRIS

We recently submitted a scientific advice (SA)/protocol assistance (PA) request via IRIS for a US based SME with an Orphan …

Read more

View Brexit and the end of the transition period

Brexit and the end of the transition period

EU rules will no longer apply to most of the UK from 31st December 2020. But it’s not that simple! …

Read more

View Scientific Advice through the EMA Regulatory & Scientific Information Management Platform from October 19th 2020

Scientific Advice through the EMA Regulatory & Scientific Information Management Platform from October 19th 2020

From October 19th this year, Scientific Advice applications will need to go through the EMA Regulatory and Scientific Information Platform …

Read more

View The Changing Face of Pharma Communications Online Forum

The Changing Face of Pharma Communications Online Forum

We at Agos are looking forward to this online gathering of selected senior industry colleagues and expert guests from the …

Read more

View SME in Europe

SME in Europe

Agos Pharma have just renewed the SME status of our Irish subsidiary. This means we can access the excellent benefits …

Read more

View Borderline Medicines and Medical Devices

Borderline Medicines and Medical Devices

A number of our USA clients have come to us for help in Europe when developing a medicinal product or …

Read more

View Update on Clinical Trial Regulation “Application”

Update on Clinical Trial Regulation “Application”

The Clinical Trials Regulation will not be applied, and the Clinical Trial Directive will not be repealed, until full functionality …

Read more
  1. Pages:
  2. 1
  3. 2